Skip to main content

Table 2 The correlation between clinicopathological factors and CRP/Alb ratio in ovarian cancer patients (n = 200)

From: The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer

Variable

No. of patients

P value

CRP/Alb <0.68

CRP/Alb ≥0.68

 

Age

≤50 years

59

25

0.23

>50 years

72

44

 

Tumor stage

  

0.001

 FIGO I

23

2

 

 FIGO II

27

6

 

 FIGO III

63

44

 

 FIGO IV

18

17

 

Grade

 G1

40

15

0.325

 G2

52

34

 

 G3

39

20

 

Residual tumor

  

0.049

  ≤ 2 cm

94

40

 

  > 2 cm

37

29

 

Histological type

  

0.552

 Serous

76

45

 

 Mucinous

18

9

 

 Endometrioid

10

4

 

 Clear cell

8

6

 

 Others

19

5

 

Ascites

  

0.009

 N0

96

38

 

 Yes

35

31

 

Albumin

  

<0.001

≤35 g/L

6

18

 

>35 g/L

125

51

 

CRP level

  

<0.001

  ≤ 10 mg/L

90

0

 

  > 10 mg/L

41

69

 

CA-125(U/mL)

  

0.002

  ≤ 35

16

0

 

  > 35

115

69

 

GPS(0/1/2)

91/35/5

0/53/16

<0.001

mGPS(0/1/2)

90/37/4

0/53/16

<0.001

PNI(0/1)

100/31

46/23

0.143

NLR(0/1)

110/21

50/19

0.053

PI(0/1/2)

59/58/14

26/37/6

0.452

PLR(0/1)

56/75

9/60

<0.001

Survival(months)

43.12(2.08–104.27)

24.32(0.85–68.79)

<0.001

  1. FIGO International Federation of Gynecologists and Obstetricians, G grade, CRP C-reactive protein, CA cancer antigen, GPS Glasgow Prognostic Score, mGPS modified, GPS NLR Neutrophil lymphocyte ratio, PLR Platelet lymphocyte ratio, PI Prognostic index, PNI Prognostic Nutritional Index
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us